Adagene (ADAG) Other Non-Current Liabilities (2020 - 2025)
Adagene's (ADAG) quarterly Other Non-Current Liabilities came in at $205.1 billion in Q4 2025, up 641.16% on a QoQ basis from $27.7 billion in Q2 2023.
Adagene (ADAG) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
Adagene (ADAG) has 5 years of Other Non-Current Liabilities data on file, last reported at $205.1 billion in Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $205.1 billion in Q4 2025; TTM through Dec 2025 was $205.1 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $205.1 billion, changed N/A from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $205.1 billion, up from $27.7 billion in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for ADAG reached as high as $205.1 billion in Q4 2025 and fell as low as $61919.0 in Q2 2021.
- Historically, Other Non-Current Liabilities has averaged $48.6 billion across 4 years, with a median of $28.2 billion in 2022.
- Across the five-year window, Other Non-Current Liabilities soared 48127292.24% in 2022 and fell 7.12% in 2023, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $94107.0 in 2021, then soared by 30516227.16% to $28.7 billion in 2022, then dropped by 3.62% to $27.7 billion in 2023, then soared by 641.16% to $205.1 billion in 2025.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $205.1 billion in Q4 2025, $27.7 billion in Q2 2023, and $28.7 billion in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 205.15 Bn |
| Jun 30, 2023 | 27.68 Bn |
| Dec 31, 2022 | 28.72 Bn |
| Jun 30, 2022 | 29.80 Bn |
| Dec 31, 2021 | 94,107.00 |
| Jun 30, 2021 | 61,919.00 |
| Dec 31, 2020 | 91,955.00 |